Developed and implemented business plans in order to deploy distribution, sales, and marketing strategies for Mexico, Puerto Rico and the United States. Perform methodical analysis and selection of sales strategies to organize and manage existing and emerging markets with the most effective and efficient channels, to reach accelerated growth that exceeds 20%, achieving the widest customer base.

Establish and champion project deliverables and milestones including, but not limited to: Scope Development, Engineering, Construction, Outages, Clearances, Database, Safety practices, procedures, goals and metrics.

Recruited as Regional Director of Latin America Channel Management to lead, restructure and manage all Channels and Distribution network for all Pall products lines. Pall is well-recognized worldwide for manufacturing the highest quality filtration and separation products and technologies.Appointed Business Development & Channel Management Director for the America’s Territory in 2013; fully responsible for all activities in Canada, US, and Latin America. Currently manage and support operations in 25+ countries, 85+ distributors, 15+ sales representatives, 4,500+ direct customers, and 450+ channels. ▬ Increased revenues and new markets in Latin America.▬ Managed acquisition of largest distributor in Latin America (Brazil).▬ Re-evaluated Channel network to successfully comply with legal requirements in the divestiture of the Pall medical blood business.▬ Lead key activities in implementing the SAP enterprise system in Brazil and Argentina distribution legal entities; recognized as one of the most successful implementation worldwide.▬ Perform methodical analysis and selection of sales strategies to organize and manage existing and emerging markets.▬ Reviewed structure, changed or modified contracts and mitigated company risk. Updated, negotiated and secured Distributors and Sales Representatives contracts for all the corporation businesses with activities in the Americas.▬ Spearhead quarterly Business Plan Reviews with distributors and commercial leaders to assure Annual Operating Plan objectives and projections are met.▬ Ensure full compliance on Anti-bribery and Anti-corruption Federal Acts and other related legal aspects with distributors and company regional commercial leaders in the Americas.

Developed financial product portfolio for entire company. This consisted of the integration of small business operational consulting and the development of financial strategies throughout the sale of financial products such as Export / Import Financing, Medical and Government Factoring, Secured and Unsecured Lines of Credit, Merchant Finance and equipment leasing. Recruited and provided leadership and direction to a 25-person Sales Team. Established performance metrics and managed company’s budget. Developed innovative products that were to be marketed by the company. ▬ Developed and implemented the vision, mission, strategy, policies and procedures to achieve company objectives and support an aggressive sales plan with target revenue of $1.1 million dollars for 2008. ▬ Searched, analyzed and launched new financial products suite with the main goal of reducing cost to customers by 10%.

Recruited on exact date of TEVA Pharmaceuticals $7.0 billion acquisition of IVAX Pharmaceuticals. Responsible for the Supply Chain & Materials Management organization and for leading the strategic integration of both company’s Supply Chain Management teams and products across 13 facilities worldwide. Managed 6 Direct Reports: Director of Purchasing, Director of Production Planning, Director of Materials Management, Manager Inventory Control, Manager Strategic Planning and SIOP, and Manager Outsourced Manufacturing. Managed team of 35 corporate and 35 operational employees including career development, performance management, and skills realignment to the Purchasing and Planning functions for the business (all 13 facilities worldwide).▬ Developed and implemented vision, strategy, policies and procedures to achieve corporate objectives and support an aggressive sales plan with targeted revenues for FY 2006 of $7.8 billion dollars.▬ Reengineered Sales, Inventory, Operations & Planning process, resulting in new Supply Plan for the combined enterprise.▬ Established performance metrics and managed department performance against metrics target for combined TEVA / IVAX.▬ Identified key resources, established stringent timetables and raised staff performance levels in order to achieve on time/on budget delivery of new products.▬ Cost reduction initiatives such as inventory reduction, Purchase Price Variance (PPV), transportation contract re-negotiation and product rationalization exceeded $1.3 million.

Managed operations with $2 billion in sales and stabilize and grow a new $300 million revenue stream. Devised and implemented strategic plan to restructure department; reviewed all procedures, re-certified staff and developed new contingency / capacity plans. Managed 7 direct reports: Manager of Materials Planning, Manager of Production Planning, 5 supervisors: Warehouse Supervisor, 4 Production Planning Supervisors. Managed team of 80 employees including career development, performance management and $12 million operating budget. ▬ Led re-engineering of Sales and Operations Planning Process for the entire company supporting the Cardiovascular, Endovascular and Neurovascular Franchises with sales of $1.9 billion.

Supply Chain Manager (1997-1998) Production Planning Manager (1995-97) Master Scheduler (1993-95)Developed and implemented strategic models for process improvements in capacity maximization, cost reduction, tax & VAT minimization utilizing newly adopted SAP / Planning software.▬ Directed Sales, Inventory and Operations Planning process (SIOP) for 4 international and 1 domestic manufacturing plants within the Anti-Infective Franchise for 3,000 generic and branded dosage forms (Oral suspensions, capsules, tablets and sterile vials).▬ Managed $600 million in raw materials inventory for $2.4 billion organization.